Answer
The selected injection formulation is licensed for ilioinguinal or iliohypogastric nerve-block analgesia in children. Evidence is unavailable for infants younger than 6 months, and other paediatric uses are not established in that product information.
Sources for this answer
- Levobupivacaine 25mg/10ml Solution for injection/infusion ampoules (2.5mg/ml) — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.